Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06503939 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 8 more changesShow less
    • Trial status changed: Unknown → Completed
    • Final enrollment: 750 participants (planned 600)
    • Primary completion date changed from estimate of Dec 31, 2024 to Mar 31, 2024
    • Trial arms changed: 0 → 3
    • Start date: Sep 1, 2023 to Mar 1, 2023
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoint revised
    • Study description expanded, about 66 words
  2. Changed Registry marked status Unknown; last known: Enrolling by Invitation
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this real-world study, we retrospectively classified the causes of chronic cough in patients, analyzed the prevalence of cough-variant asthma, and prospectively evaluated and compared the improvement of cough symptoms and quality of life after ICS/LABA or non-ICS/LABA treatment.
Trial Details
NCT Number NCT06503939
Lead Sponsor Xiangya Hospital of Central South University
Conditions
(from sponsor)		 Chronic Cough, Long COVID
Related terms Chronic Cough, Post-Acute COVID-19 Syndrome
Enrollment 750 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov